Home > Insider Trading > Intellia Therapeutics Inc.

Intellia Therapeutics Inc. (NTLA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript

Operator: Good morning, and welcome to Intellia Therapeutics’ First Quarter 2024 Financial Results Conference Call. My name is Drew, and I will be your conference operator today.

Keep Reading →

May 10th, 2024 - News Transcripts

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings Call Transcript

Intellia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.46, expectations were $-1.47. Intellia Therapeutics, Inc.

Keep Reading →

February 23rd, 2024 - News Transcripts

Top 11 CRISPR Stocks To Invest In

Genome editing refers to a set of technologies enabling scientists to modify an organism's DNA by adding, removing, or altering genetic material at specific locations in the genome, as defined by MedlinePlus...

Keep Reading →

February 10th, 2024 - Hedge Funds News

13 Most Promising Future Stocks To Buy According To Hedge Funds

In this piece, we will take a look at the 13 most promising stocks to buy according to hedge funds.

Keep Reading →

December 27th, 2023 - Hedge Funds News

5 Most Promising Biotech Stocks to Buy According to Analysts

In this article, we will take a look at the 5 most promising biotech stocks to buy according to analysts.

Keep Reading →

December 15th, 2023 - Hedge Funds News

5 Best Genomics Stocks To Buy Now

Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a gene editing company developing treatments for cancer and immune system diseases.

Keep Reading →

December 10th, 2023 - Hedge Funds

Top 20 Genomics Companies in the World

In this piece, we will take a look at the top 20 genomics companies in the world.

Keep Reading →

October 30th, 2023 - Industries Lists News

16 Best Stocks to Buy and Hold for the Next 15 Years According to Cathie Wood's Portfolio

In this article, we will take a look at the 16 best stocks to buy and hold for the next 15 years according to Cathie Wood's portfolio.

Keep Reading →

October 16th, 2023 - Hedge Funds News

5 Biotech Stocks with Biggest Upside

In this article, we discuss 5 biotech stocks with biggest upside.

Keep Reading →

September 9th, 2023 - News

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2023 Earnings Call Transcript

Operator: Good morning and welcome to the Intellia Therapeutics' Second Quarter 2023 Earnings Conference Call. My name is Drew and I will be your conference operator today.

Keep Reading →

August 5th, 2023 - News Transcripts